SUBCUTANEOUS ABSORPTION KINETICS AND LOCAL TISSUE DISTRIBUTION OF INTERFERON AND OTHER SOLUTES

被引:16
作者
CROSS, SE [1 ]
ROBERTS, MS [1 ]
机构
[1] UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,DEPT MED,BRISBANE,QLD 4102,AUSTRALIA
关键词
D O I
10.1111/j.2042-7158.1993.tb05661.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The subcutaneous absorption and consequent tissue distribution of interferon g was studied in an anaesthetized rat model. Interferon g showed a biphasic disappearance profile from a solution in a subcutaneous absorption cell. Both the initial rapid distribution phase and slower removal phase followed first order kinetics. The steady-state clearance of interferon g from the cell was 1.41 +/- 0.38 x 10(-3) mL min-1, and the absorption half-life (t1/2) was 3.8 +/- 1.1 h (n = 4). Noradrenaline did not significantly alter either the clearance or absorption of interferon g (1.18 +/- 0.44 x 10(-3) mL min-1, P > 0.05, absorption t1/2 4.96 +/- 1.9 h, P > 0.05). Given that the clearance of smaller solutes, such as tritiated water, is significantly reduced when noradrenaline is coadministered, it is suggested that interferon g is removed via the lymphatic system rather than by the local blood supply. The amount of interferon g recovered in the plasma, urine and muscle is minimal relative to other solutes where the recovery is almost complete.
引用
收藏
页码:606 / 609
页数:4
相关论文
共 15 条
[1]   METABOLISM OF PROTEIN ANTICANCER AGENTS [J].
BOCCI, V .
PHARMACOLOGY & THERAPEUTICS, 1987, 34 (01) :1-49
[2]  
BOCCI V, 1988, J BIOL RESP MODIF, V7, P390
[3]  
COURTICE FC, 1981, STRUCTURE FUNCTION C, V2, P487
[4]  
DEMAEYER E, 1982, PHILOS T ROY SOC B, V299, P77
[6]   VIRUS INTERFERENCE .1. THE INTERFERON [J].
ISAACS, A ;
LINDENMANN, J .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927) :258-267
[7]  
LEVY RH, 1972, PHARM SCI, V61, P1263
[8]   THE ROLE OF ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS IN THE RESPONSE TO NORADRENALINE OF LYMPHATIC VESSELS ISOLATED FROM THE BOVINE MESENTERY [J].
MAHE, L ;
CHAPELAIN, B ;
NELIAT, G ;
GARGOUIL, YM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 167 (01) :31-39
[9]  
PAASKE WP, 1989, DAN MED BULL, V36, P570
[10]   A COMPARISON OF SUBCUTANEOUS AND INTRAMUSCULAR ADMINISTRATION OF HUMAN GROWTH-HORMONE IN THE THERAPY OF GROWTH-HORMONE DEFICIENCY [J].
RUSSO, L ;
MOORE, WV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (05) :1003-1006